Study Completed

Dermatitis, Atopic

Bayer Identifier:

Trial_308962

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study to compare the efficacy and safety of Advantan ointment once daily with Protopic 0.03% ointment twice daily in children and adolescents with atopic dermatitis

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

2 - 15 Years

Trial summary

Enrollment Goal

265

Trial Dates

March 2005 - August 2005

Phase

Phase 4

Could I Receive a placebo

N/A

Products

Advantan (Methylprednisolone Aceponate, BAY86-4862)

Accepts Healthy Volunteer

N/A

Trial design

Double-blind, randomized, reference-controlled, multicenter, parallel-group study to compare the efficacy and safety of Advantan ointment once daily with Protopic 0.03% ointment twice daily over maximum 3 weeks in 250 children and adolescents with atopic dermatitis

Trial Type

Interventional

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.